References
- Kher V, Gulati S. Mesangiocapillary glomerulonephritis. Oxford Textbook of Clinical Nephrology. 3rd ed. Oxford: Oxford University Press; 2005
- Alchi B, Jayne D. Membranoproliferative glomerulonephritis. Pediatr Nephrol. 2010;25:1409–1418
- Nakopoulou L. Membranoproliferative glomerulonephritis. Nephrol Dial Transplant. 2001;16(Suppl 6):71–73
- Orth SR, Ritz E. The nephrotic syndrome. N Engl J Med. 1998;338:1202–1211
- Iitaka K, Nakamura S, Moriya S, et al. Hypocomplementemia and membranoproliferative glomerulonephritis in children. Clin Exp Nephrol. 2005;9:31–33
- Safaei A, Maleknejad S. Spectrum of childhood nephrotic syndrome in Iran: A single center study. Indian J Nephrol. 2009;19:87–90
- National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics. 2004;114:555–576
- Schwartz GJ, Haycock GB, Edelmann Jr CM, Spitzer A. A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics. 1976;58(2):259–263
- West CD, McAdams AJ, McConville JM, Davis NC, Holland NH. Hypocomplementemic and normocomplementemic persistent (chronic) glomerulonephritis: Clinical and pathologic characteristics. J Pediatr. 1965;67:1089–1112
- Wei C-C, Wang W, Smoyer WE, Licht C. Trends in pediatric primary membranoproliferative glomerulonephritis costs and complications. Pediatr Nephrol. 2012;27:2243–2250
- Schwertz R, De Jong R, Gretz N, Kirschfink M, Anders D, Scharer K. Outcome of idiopathic membranoproliferative glomerulonephritis in children. Acta Pediatr. 1996;85:308–312
- Asinobi AO, Gbadegesin RA, Adeyemo AA, et al. The predominance of membranoproliferative glomerulonephritis in childhood nephrotic syndrome in Ibadan, Nigeria. West Afr J Med. 1999;18:203–206
- D'Agati VD, Bomback AS. C3 glomerulopathy: What's in a name? Kidney Int. 2012;82(4):379–381
- Bomback AS, Appel GB. Pathogenesis of the C3 glomerulopathies and reclassification of MPGN. Nat Rev Nephrol. 2012;8(11):634–642
- Schmitt H, Bohle A, Reineke T, Mayer-Eichberger D, Vogl W. Long-term prognosis of membranoproliferative glomerulonephritis type 1. Nephron. 1990;55:242–250
- Cansick JC, Lennon R, Cummins CL, et al. Prognosis, treatment and outcome of childhood mesangiocapillary (membranoproliferative) glomerulonephritis. Nephrol Dial Transplant. 2004;19(11):2769–2777
- Somers M, Kertesz S, Rosen S, et al. Non-nephrotic children with membranoproliferative glomerulonephritis: Are steroids indicated? Pediatr Nephrol. 1995;9(2):140–144
- Donadio JV, Holley KE. Membranoproliferative glomerulonephritis. Semin Nephrol. 1982;2:204–209
- Levin A. Management of membranoproliferative glomerulonephritis: Evidence-based recommendations. Kidney Int. 1999;55(Suppl 70):41–46
- Alchi B, Jayne D. Membranoproliferative glomerulonephritis. Pediatr Nephrol. 2010;25:1409–1418